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1043-107 Assessment of Pacing Algorithms In Prevention of 
Atrial Fibril lation 
Jacoues Mansourati. Claude Barnay, Jean-Louis Maroon, Luc De Roy, Fran(~oise 
Hidden-Lucet, Yann Poezevara, Jean-Jacques Blanc, On behalf of the PIPAF study 
group, University Hospital of Brast, Brest, France, ELA recherche, Le Plessis Robinson, 
France. 
Background : Superiority of additional algorithms (alg) over baseline AAI 70 bpm pacing 
for atrial fibrillation (AF) prevention remains controversial, 
Aim : To test the effect of 3 alg in pts with documented paroxysmal (P) AlE 
Methods : Pts with at least 3 episodes of AF dudng the last year (with or without brady- 
cardia) were included in this multicentre, randomized, cross-over study (3 months each). 
After informed consent, pts were implanted with a DDD (chorum 7334 ELA Montrouge; 
France) pacemaker (atrial ead in the dght atrial appendage). After one month, they were 
randomly assigned to DDD pacing at 70 bpm (DDD 70) or DDD pacing at 70 bpm plus 
alg (DDD 70 + alg). The 3 alg are: Sinus Rhythm Overdrive achieves permanent atrial 
pacing just above the sinus rate ; Post-Extrasystolic Pause Suppression controls the 
variation of cycle length after a premature atrial contraction (PAC); Acceleration on PAC's 
increases tamporadly pacing rate upon frequent PAC's. Study end point was recurrences 
(number and duration) of PAF detected by pacemaker. 
Results : Follow-up was completed in 38 pts (68 + 11y), Symptoms were present in 94 % 
of pts, and 86 % had anti-arrhythmic drug therapy. 
DDD 70 DDD 70 + alg p 
Nb of episodes/week 6.0 ± 10.4 5.9 + 8.7 ns 
Duration (hours) 12.0 + 24.2 11.7 + 23.5 ns 
DDD 70 + alg was associated with a reduction of AF episodes in 20 pts, an increase in 14 
pts. 4 pts did not exhibit any AF recurrences dudng both pacing modalities. 
Conclusion : Sophisticated alg provided in the DDD pacemaker did not yield any benefit 
when compared to DDD 70 pacing in pts with PAlE In some pts, DDD pacing alone pro- 
vides a dramatic reduction of PAlE 
1043-108 Single and Dual Site Atrial Lead Location Alter the 
Acute Hemodynamic Response to AtriaI-Ventricular 
Delay 
Huno-Fat Tss. Chu Pak Lau, Douglas A. Hettrick, University of l-tong Kong, Queen Mary 
Hospital Hong Kong, Medtronic Inc., Minneapolis, Minnesota. 
Background: Alternate site right-atrial, dual-site right atrial and bi-atrial lead configura- 
tions have all been proposed as alternatives to right atrial appendage lead location. We 
tested the hypothesis that these alternate lead locations may differentially affect left 
atrial-ventricular mechanical coupling and hence global hemodynamic indices such as 
pulse pressure (PP). Methods: Nine patients (5M, 46±15y) with standard indication for 
EP study were included. Hemodynamic variables including PP and mean right atrial 
pressure (RAP) were recorded during dual chamber pacing at cycle lengths of 500 and 
350 ms and AV delays of 0, 50, 100, and 150 ms from the high right atrium (HRA), distal 
coronary sinus (DCS), HRA+DCS, HRA + coronary sinus ostium (HRA+CSO), and the 
inter-atdal septum (IAS). Results: PP was higher and RAP lower during pacing at 500 vs. 
350 ms regardless of lead location. PP vaded differently with AV delay depending on lead 
location at cycle lengths of 500 ms (table) and 350 ms. Conclusion: Optimal PP occurred 
at specific but different AV delays for vadous atrial lead locations and configurations. 
Hence, hemodynamic optimization should be considered when programming devices 
with alternative atrial lead placement. HRA (or HRA+CSO) pacing appears to be hemo- 
dynamically preferable in patients without structural HD and normal inter-atrial conduc- 
tion. Improved hemedynamic performance may slow the progression of atdal fibrillation 
and congestive heart failure. 
Arterial Pulse Pressure (mmHg), CL=500 ms 
AV Delay (ms) 
Pacing Site 0 50 1OO 150 n 
HRA 52±14 52±13 60±13" 58±13 8 
DCS 42±8 47±10 52±11" 50±14" 7 
HRA+DCS 45±9 47±8 48±8 46±10# 9 
HRA+CSO 43±9 50±13 48±13 54±18" 6 
IAS 39±8 44±10 48±14 49±16 6 
mean±SD, *p<0.05 vs. 0 ms, #p<0.05 vs. HRA at 150 ms 
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1043-109 Pacing Prevention of Atrial Tachyerrhythmlas: 
Prel iminary Results From the Italian ATS00 Registry 
GianLuca Botto. Luigi Pedeletti, Renato Ricci, Giuseppe Inama, Annibale S. Montanero, 
Alessandro Capucci, Giuseppe Bodani, Paoio DellaBella, Alessandro Proclemer, Andrea 
Grammatico, S. Anna, Como, Italy, Medtronic Italia, Rome, Italy. 
Background. Pacing prevention algorithms have been proposed to interact with atrial 
tachyarrhythmias (AT) onset mechanisms and limit AT recurrences. The Medtronic 
AT500 is a new DDDRP pacing system with prevention pacing algodthms, such as atdal 
rate stabilization, atrial pacing preference and post mode-switch overdrive pacing, 
Methods. 105 pts (54 M, mean age 71±9 years) were implanted with the AT500 pace- 
maker. Implant indication was sinus node dysfunction or AV block associated to AT in 91/ 
105 pts, AT alone in 7/105 pts and sinus node dysfunction alone in 7/105 pts. After 
implant all prevention algorithms were disabled at least for a 1 month period. Afterwards 
they were enabled. The pacemaker diagnostics allowed to monitor the following clinical 
parameters: AT episodes number, AF burden, premature atrial contractions (PAC), atrial 
(AP%) and ventricular (VP%) pacing percentage, atdal (A bpm) and ventricular (V bpm) 
beats per minute. Results, 50/98 pts suffered from AT recurrences in a mean follow up 
period of 3,5¢2.0 months. Clinical parameters were compared in the period with preven- 
tion algorithm ON vs OFF, as resumed in the table below. Conclusions, Prevention algo- 
rithms achieved a significant atrial overdrive pacing, enhancing of just few beats per 
minute the atrial and ventdcular frequency, with good patient tolerance. Prevention fea- 
tures significantly reduced PACe per day. A trend toward reduction of AT recurrences and 
AF burden was observed. 
Prevention algorithms OFF Prevention algorithms ON P value 
AP% 69 +/-27 95+/-8 0.01 
VP% 74+/-32 77+/-34 ns 
A bpm 69+#11 73+/-11 ns 
V bpm 75+/-9 77+#10 ns 
PAC per day 2981 +/-8912 769+/-1789 0.05 
AT episodes per day 2.6+#14.4 2.0+/-12,9 ns 
AF burden (hour per day) 3.3+/-7,9 2.2+/-6.6 ns 
1043-110 Long-Term Outcome of Dual Site Right Atrial Pacing in 
Patients With Drug-Refractory Paroxysmal Versus 
Persistent or Permanent Atrial Fibril lation 
Sanieav Saksena. Wen H. Lin, Atul Prakash, Artur Filipecki, Atlantic Health System 
(Passaic), Passaic, New Jersey, Electrophysio/ogy Research Foundation, Millbum, New 
Jersey. 
Honpharmecologic therapies (rx) have been individually tested in patients(pts) with drug- 
refractory AF, but variable study populations and limited efficacy have impeded definition 
of a therapeutic role. Methods: A "hybrid" strategy for management of refractory atrial 
fibrillation (AF) was implemented in pts with drug-refractory AF from 1994-2000. Dual site 
atrial pacing (DAP) and/or focal or linear atdal ablation was used for AF prevention & DC 
cardioversion (CV) was employed if AF recurred and required termination. We compared 
the Rx employed and clinical outcome of 113 pts, mean age 69±11 yrs, with paroxysmal 
(n=70, Gp. 1) and persistent or permanent AF (n=43, Gp. 2). During mean follow-up of 
30±23 months, survival, freedom from permanent AF (rhythm control) and CV were ana- 
lyzed. Results: Overall survival at 3 yrs was better in Gp. 1 (89%) than in Gp. 2 (74%, 
p<.001). Rhythm control was comparable in both groups at 2 & 4 yrs (Figure). There was 
a greater overall need for CV in Gp, 2 (p<.05). While early recurrence of AF was equally 
common in both groups, late recurrences requiring CV were more frequent in Gp. 2 
(p<.05), AF prevention required atdal ablation more often in Gp.2. (42%) as compared to 
Gp. 1 (26%, p<.05). ~oncluslons: 1."Hybrid" therapy is comparably effective in achiev- 
ing long-tarm rhythm control in both paroxysmal and persistent or permanent AF.2. Atria~ 
ablation and serial CV are more frequently required in persistent or permanent AF for 
rhythm control, but survival is more limited in this population 
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